New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology - Wikidata - wikimedia - TriplyDB

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

http://www.wikidata.org/entity/Q26745678

about

Regulation of DNA Alkylation Damage Repair: Lessons and Therapeutic Opportunities.Could NAMPT inhibition become a potential treatment option in hepatocellular carcinoma?Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy.Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA.

P2860

Q38999756-40B07043-A2B8-4026-BB94-D8F25C39C58A Q45937975-2B4EDE1A-A066-4DE8-A98B-010422E2E44A Q47131402-8FC98E59-DCC6-4917-9947-03FAD2255B92 Q52316501-2C8F51F5-35BE-42DD-AAC1-C834BE172336

P2860

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

http://www.wikidata.org/entity/Q26745678

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@ast

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@en

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@nl

type

label

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@ast

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@en

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@nl

prefLabel

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@ast

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@en

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@nl

P1433

Q26745678-A5D2A5E9-A4C1-4326-A1A7-D4D148F96472

P1476

Q26745678-3956F20D-1FE1-4F88-8258-70239984701A

P2093

Q26745678-3EB2CA41-0584-428C-B32B-2176A3BCBDF9

Q26745678-D545BF32-527F-4975-BC73-1CDBE79F8786

P2860

Q26745678-00C90FE3-68A3-4F3B-A3CD-E7ABBE367735

Q26745678-0528B798-1E3B-4181-B8A7-6F1C8023A5D4

Q26745678-07CA7488-1532-4FCC-8F73-10F58180EF68

Q26745678-0E435778-5F7E-48E3-BA55-B0098A91A9BD

Q26745678-1E8CF255-82FC-431A-AE3B-64125F539D81

Q26745678-211870F7-F726-458B-BA81-B6C46B5EA48B

Q26745678-241E806B-C09E-440B-B82B-C2E50D1C9B8E

Q26745678-2703A0BC-109B-48B3-8E17-3909AB6E084D

Q26745678-33DA3FCE-8D24-4000-80E0-6FAD636FAFA2

Q26745678-393E7BAD-18BC-46EF-B772-32277DEEAE86

P304

Q26745678-942C9942-B02C-45DA-938B-0FDCAD21000F

P31

Q26745678-E9BCBEE7-1C46-4449-986F-C421F7F2845B

P356

Q26745678-0ED40B46-33F4-4236-B006-03771AAFCAE0

P407

Q26745678-6D33F615-6A7C-452D-860E-99558E8C3FD7

P433

Q26745678-23569851-0FEC-4008-825C-9B1760B51E7E

P478

Q26745678-1F1926D2-DF00-4824-B4EE-761D5341AE76

P577

Q26745678-90A4358F-D992-4454-8307-F6612554514F

P5875

Q26745678-ECE9A8DC-8F97-45D6-8A5F-854A5C752BD0

P698

Q26745678-50437D99-235D-406C-ACB1-ED1FB5BFF858

P932

Q26745678-353DDF2F-0F15-47A8-8490-719CB4E7EF62

P356

23723556.2015.1052180

P1433

Molecular & cellular oncology

P1476

New strategies to maximize therapeutic opportunities for NAMPT inhibitors in oncology

@en

P2093

Anne Roulston

http://www.w3.org/2001/XMLSchema#string

Gordon C Shore

http://www.w3.org/2001/XMLSchema#string

P2860

Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme

Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells

Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms

Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival

Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy

The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism

Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)

Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase

Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors.

P304

e1052180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/23723556.2015.1052180

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279281444

http://www.w3.org/2001/XMLSchema#string

P698

27308565

http://www.w3.org/2001/XMLSchema#string

P932

4845202

http://www.w3.org/2001/XMLSchema#string